WO2000048445A2 - Pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit - Google Patents
Pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit Download PDFInfo
- Publication number
- WO2000048445A2 WO2000048445A2 PCT/EP2000/000975 EP0000975W WO0048445A2 WO 2000048445 A2 WO2000048445 A2 WO 2000048445A2 EP 0000975 W EP0000975 W EP 0000975W WO 0048445 A2 WO0048445 A2 WO 0048445A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- deoxypeganine
- treatment
- nicotine
- nicotine addiction
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU26706/00A AU2670600A (en) | 1999-02-19 | 2000-02-08 | Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence |
US09/889,650 US6548510B1 (en) | 1999-02-19 | 2000-02-08 | Pharmaceutical composition containing deoxypeganine for the treatment of nicotine dependence |
EP00905035A EP1150681B1 (de) | 1999-02-19 | 2000-02-08 | Verwendung einer pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit |
DE50012014T DE50012014D1 (de) | 1999-02-19 | 2000-02-08 | Verwendung einer pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit |
JP2000599251A JP4287596B2 (ja) | 1999-02-19 | 2000-02-08 | ニコチン依存症の治療のためのデオキシペガニン含有医薬組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19906979.4 | 1999-02-19 | ||
DE19906979A DE19906979B4 (de) | 1999-02-19 | 1999-02-19 | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000048445A2 true WO2000048445A2 (de) | 2000-08-24 |
WO2000048445A3 WO2000048445A3 (de) | 2001-04-26 |
Family
ID=7898025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/000975 WO2000048445A2 (de) | 1999-02-19 | 2000-02-08 | Pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit |
Country Status (12)
Country | Link |
---|---|
US (1) | US6548510B1 (de) |
EP (1) | EP1150681B1 (de) |
JP (1) | JP4287596B2 (de) |
KR (1) | KR100681631B1 (de) |
AR (1) | AR022621A1 (de) |
AT (1) | ATE314850T1 (de) |
AU (1) | AU2670600A (de) |
DE (2) | DE19906979B4 (de) |
DK (1) | DK1150681T3 (de) |
ES (1) | ES2255977T3 (de) |
PT (1) | PT1150681E (de) |
WO (1) | WO2000048445A2 (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003007966A1 (de) * | 2001-07-12 | 2003-01-30 | Hf Arzneimittelforschung Gmbh | Wirkstoff-kombination zur medikamentösen therapie der nikotinabhängigkeit |
WO2003053445A1 (de) * | 2001-12-21 | 2003-07-03 | Hf Arzneimittelforschung Gmbh | Verwendung von desoxypeganin zur behandlung der klinischen depression |
WO2008007163A1 (en) * | 2006-07-11 | 2008-01-17 | Adnan Jathlan Al-Rehaily | Peganine isolated from anisotes trisulcus l. as a smoking deterrent and anorxigenic agent |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10119863A1 (de) * | 2001-04-24 | 2002-11-07 | Hf Arzneimittelforsch Gmbh | Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen |
DE10129265A1 (de) * | 2001-06-18 | 2003-01-02 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie |
DE10304141B4 (de) | 2003-02-03 | 2006-03-09 | Hf Arzneimittelforschung Gmbh | Verfahren zur Herstellung von Chinazolin-Alkaloiden |
DE10354893B4 (de) * | 2003-11-24 | 2011-03-10 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen |
DE10354894A1 (de) * | 2003-11-24 | 2005-07-07 | Hf Arzneimittelforschung Gmbh | Orale Formulierungen des Desoxypeganins und deren Anwendungen |
KR101831463B1 (ko) | 2010-03-26 | 2018-02-22 | 필립모리스 프로덕츠 에스.에이. | 비흡연성 담배 제품의 소비 시 감각 자극의 억제 |
US8952038B2 (en) | 2010-03-26 | 2015-02-10 | Philip Morris Usa Inc. | Inhibition of undesired sensory effects by the compound camphor |
US10335378B2 (en) | 2013-03-15 | 2019-07-02 | Altria Client Services Llc | Inhibition of central nervous system effects from smoking and sensory effects from smoking |
CN104382964B (zh) * | 2014-10-27 | 2017-07-28 | 上海中医药大学 | 一种由骆驼蓬草制备骆驼蓬草总生物碱提取物和骆驼蓬草总黄酮提取物的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000048579A1 (de) * | 1999-02-19 | 2000-08-24 | Lts Lohmann Therapie-Systeme Ag | Desoxypeganin-tts |
DE19906975A1 (de) * | 1999-02-19 | 2000-08-24 | Lohmann Therapie Syst Lts | Vorrichtung und Verfahren zur Behandlung von Alzheimer'scher Demenz |
DE19906974A1 (de) * | 1999-02-19 | 2000-08-31 | Lohmann Therapie Syst Lts | Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung des Alkoholismus |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3797494A (en) | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US3760805A (en) | 1971-01-13 | 1973-09-25 | Alza Corp | Osmotic dispenser with collapsible supply container |
US3742951A (en) | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
US3996934A (en) | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
SU605614A1 (ru) * | 1971-10-20 | 1978-05-05 | Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср | Антихолинэстеразное средство |
US3987790A (en) | 1975-10-01 | 1976-10-26 | Alza Corporation | Osmotically driven fluid dispenser |
US4031894A (en) | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
US4137300A (en) | 1976-08-20 | 1979-01-30 | Ciba-Geigy Corporation | Sustained action dosage forms |
DE3315272C2 (de) | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
US4597961A (en) | 1985-01-23 | 1986-07-01 | Etscorn Frank T | Transcutaneous application of nicotine |
DE3629304A1 (de) | 1986-08-28 | 1988-03-24 | Lohmann Gmbh & Co Kg | Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung |
DE3843239C1 (de) | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts |
-
1999
- 1999-02-19 DE DE19906979A patent/DE19906979B4/de not_active Expired - Fee Related
-
2000
- 2000-02-08 AU AU26706/00A patent/AU2670600A/en not_active Abandoned
- 2000-02-08 EP EP00905035A patent/EP1150681B1/de not_active Expired - Lifetime
- 2000-02-08 ES ES00905035T patent/ES2255977T3/es not_active Expired - Lifetime
- 2000-02-08 PT PT00905035T patent/PT1150681E/pt unknown
- 2000-02-08 AT AT00905035T patent/ATE314850T1/de not_active IP Right Cessation
- 2000-02-08 WO PCT/EP2000/000975 patent/WO2000048445A2/de active IP Right Grant
- 2000-02-08 US US09/889,650 patent/US6548510B1/en not_active Expired - Fee Related
- 2000-02-08 JP JP2000599251A patent/JP4287596B2/ja not_active Expired - Fee Related
- 2000-02-08 DK DK00905035T patent/DK1150681T3/da active
- 2000-02-08 KR KR1020017010491A patent/KR100681631B1/ko not_active IP Right Cessation
- 2000-02-08 DE DE50012014T patent/DE50012014D1/de not_active Expired - Fee Related
- 2000-02-17 AR ARP000100678A patent/AR022621A1/es unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000048579A1 (de) * | 1999-02-19 | 2000-08-24 | Lts Lohmann Therapie-Systeme Ag | Desoxypeganin-tts |
DE19906975A1 (de) * | 1999-02-19 | 2000-08-24 | Lohmann Therapie Syst Lts | Vorrichtung und Verfahren zur Behandlung von Alzheimer'scher Demenz |
DE19906974A1 (de) * | 1999-02-19 | 2000-08-31 | Lohmann Therapie Syst Lts | Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung des Alkoholismus |
Non-Patent Citations (3)
Title |
---|
DATABASE WPI Section Ch, Week 197913 Derwent Publications Ltd., London, GB; Class B02, AN 1979-25213B XP002151986 & SU 605 614 A (AS UZB CHEM GROWING), 6. April 1978 (1978-04-06) in der Anmeldung erwähnt * |
MURATOVA, V. V. ET AL: "Toxicology of the new pharmaceutical preparation dehydroxypeganine hydrochloride" MED. ZH. UZB. (1984), (1), 53-5 , XP000957819 * |
TULYAGANOV, N. ET AL: "The pharmacological characteristics of deoxypeganine hydrochloride" FARMAKOL. TOKSIKOL. (MOSCOW) (1986), 49(3), 37-40 , XP000957689 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003007966A1 (de) * | 2001-07-12 | 2003-01-30 | Hf Arzneimittelforschung Gmbh | Wirkstoff-kombination zur medikamentösen therapie der nikotinabhängigkeit |
DE10134038A1 (de) * | 2001-07-12 | 2003-02-06 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit |
EA007628B1 (ru) * | 2001-07-12 | 2006-12-29 | Хф Арцнаймиттельфоршунг Гмбх | Сочетание действующих веществ для фармакологического лечения никотиновой зависимости |
CZ301204B6 (cs) * | 2001-07-12 | 2009-12-09 | Hf Arzneimittelforschung Gmbh | Kombinace úcinných látek pro medikamentózní terapii závislosti na nikotinu |
WO2003053445A1 (de) * | 2001-12-21 | 2003-07-03 | Hf Arzneimittelforschung Gmbh | Verwendung von desoxypeganin zur behandlung der klinischen depression |
CZ301210B6 (cs) * | 2001-12-21 | 2009-12-09 | Hr Arzneimittelforschung Gmbh | Použití desoxypeganinu k ošetrování klinické deprese |
WO2008007163A1 (en) * | 2006-07-11 | 2008-01-17 | Adnan Jathlan Al-Rehaily | Peganine isolated from anisotes trisulcus l. as a smoking deterrent and anorxigenic agent |
Also Published As
Publication number | Publication date |
---|---|
KR100681631B1 (ko) | 2007-02-09 |
AR022621A1 (es) | 2002-09-04 |
ATE314850T1 (de) | 2006-02-15 |
JP2002537232A (ja) | 2002-11-05 |
ES2255977T3 (es) | 2006-07-16 |
JP4287596B2 (ja) | 2009-07-01 |
DE19906979B4 (de) | 2004-07-08 |
EP1150681A2 (de) | 2001-11-07 |
DE19906979A1 (de) | 2000-08-31 |
EP1150681B1 (de) | 2006-01-04 |
AU2670600A (en) | 2000-09-04 |
US6548510B1 (en) | 2003-04-15 |
WO2000048445A3 (de) | 2001-04-26 |
DK1150681T3 (da) | 2006-05-22 |
KR20010102240A (ko) | 2001-11-15 |
PT1150681E (pt) | 2006-05-31 |
DE50012014D1 (de) | 2006-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0680326B1 (de) | Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit | |
EP0449247B1 (de) | Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus | |
DE69833254T2 (de) | Microdosistherapie von gefässbedingten erscheinungen durch no-donoren | |
DE60219478T2 (de) | Orale gabe von 6-hydroxy-oxymorphon als analgetikum | |
DE69811378T2 (de) | Zusammensetzungen zur behandlung von nikotinabhängigkeit, enthaltend mecamylamin und bupropion | |
EP0125634B1 (de) | Verwendung einer sekretolytisch wirkenden Substanz zur Herstellung eines Antischnarchmittels und zur Bekämpfung des Schnarchphänomens | |
DE19906979B4 (de) | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit | |
DE60017147T2 (de) | Verwendung von gabab-rezeptor agonisten und deren pharmazeutisch akzeptierbaren derivate bei der therapie zur erhaltung von nikotinabstinenz bei nikotinabhängigen patienten | |
EP0214620B1 (de) | Transdermale Applikationsform von Diltiazem | |
WO1994026270A1 (de) | Transdermale therapeutische systeme zur verabreichung von serotoninagonisten | |
CH662734A5 (de) | Antischnarchmittel. | |
EP0695182A1 (de) | Systeme zur kontrollierten abgabe von pilocarpin | |
EP0732926B1 (de) | Pharmazeutische formulierung zur prophylaxe bzw. vorbehandlung einer vergiftung durch phosphororganische cholinesterasehemmer | |
EP1154776B1 (de) | Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus | |
EP1001756B1 (de) | Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe | |
EP1656112B1 (de) | Buccale formulierungen des galanthamins und deren anwendungen | |
DE10318714B4 (de) | Wirkstoff-Kombinationen und Therapien zur Bekämpfung des Alkoholmissbrauches | |
DD297557A5 (de) | Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit | |
DE19924951B4 (de) | Verwendung von Desoxypeganin zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer | |
DE10014007A1 (de) | Neue Darreichungsformen für DSIP | |
DE69435084T2 (de) | Die Verwendung von wasserunlöslichem S-Camptothecin mit geschlossenem Lactonring für die Herstellung eines Medikamentes zur Behandlung von Darmkrebs | |
DE3430389A1 (de) | Arzneimittel fuer die gewichtsreduktion | |
DE2848938A1 (de) | Pflanzliche arzneimittel zur behandlung von hohem blutdruck | |
WO2008064815A2 (de) | Zubereitung zur transdermalen verabreichung von galanthamin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BR CA CN CZ HU IL IN JP KR MX NZ PL RU TR US ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BR CA CN CZ HU IL IN JP KR MX NZ PL RU TR US ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000905035 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09889650 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 599251 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017010491 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2000905035 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017010491 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000905035 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1020017010491 Country of ref document: KR |